Work

A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-128857

Authors: Anas Younes, Connie Lee Batlevi, Jonathon B. Cohen, Sven de Vos, Daniel J. Landsburg, Zaw Win Myint, Krish Patel, Tycel J. Phillips, Sonali M. Smith, Jason R. Westin, Anna W Ma, Dena Grayson, Reinhard von Roemeling, Stefan K. Barta

Institutions: Memorial Sloan Kettering Cancer Center, Emory University, Winship Cancer Institute, University of California, Los Angeles, University of Pennsylvania, University of Southern California, U-M Rogel Cancer Center, University of Chicago, The University of Texas MD Anderson Cancer Center, Curis (United States), Fox Chase Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2984900646

Cites:

Cited by:

Related to: 10